Status:
UNKNOWN
An EHR-based Platform To Facilitate Outcomes and Research Methods in Cerebrovascular Diseases
Lead Sponsor:
Ministry of Science and Technology of the People´s Republic of China
Collaborating Sponsors:
Dalian Jiuzhou Century Hospital
Dengzhou Central Hospital
Conditions:
Stroke
Cerebrovascular Diseases
Eligibility:
All Genders
Brief Summary
In this protocol, the investigators present methods and preliminary results from the PLATFORM-CVD Study, an EHR-based multicenter cohort. This study will focus on assessing the distribution of major c...
Detailed Description
Adherence to healthcare quality measures is needed to reduce the burden of cerebrovascular disease and improve clinical outcomes. Electronic health records (EHRs) can facilitate the standardization of...
Eligibility Criteria
Inclusion
- Patients were included in the registry if they were hospitalized with a primary diagnose of：
- cerebral infarction (I63)
- nontraumatic intracerebral hemorrhage (I61)
- nontraumatic subarachnoid hemorrhage (I60)
- transient cerebral ischemic attack and related syndromes (G45)
- intracranial and intraspinal phlebitis and thrombophlebitis (G08)
- vascular dementia (F01)
- other aneurysms (I72)
Exclusion
- Patients diagnosed with other diseases.
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
300000 Patients enrolled
Trial Details
Trial ID
NCT04775836
Start Date
January 1 2018
End Date
December 31 2021
Last Update
March 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Tiantan Hospital
Beijing, Beijing Municipality, China, 100070